0001642453 false 0001642453 2021-04-27 2021-04-27 0001642453 us-gaap:CommonStockMember 2021-04-27 2021-04-27 0001642453 us-gaap:WarrantMember 2021-04-27 2021-04-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

April 27, 2021

Date of Report (Date of earliest event reported)

 

 

DASEKE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37509   47-3913221
(State or other jurisdiction of   (Commission   (IRS Employer
incorporation)   File Number)   Identification No.)

 

15455 Dallas Parkway, Suite 550    
Addison, Texas   75001
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (972) 248-0412

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   DSKE   The NASDAQ Capital Market
         
Warrants, each exercisable for one half of a share of Common Stock at an exercise price of $5.75 per half share   DSKEW   The NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

¨    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 27, 2021, the Board of Directors (the “Board”) of Daseke, Inc. (the “Company”) appointed Catharine Ellingsen to the Board, effective as of such date. Also on April 27, 2021, the Board appointed Ms. Ellingsen to the Compensation Committee of the Board (the “Compensation Committee”) and the Corporate Governance and Nominating Committee of the Board (the “Corporate Governance and Nominating Committee”).

 

Ms. Ellingsen will receive compensation for service on the Board, the Compensation Committee and the Corporate Governance and Nominating Committee in a manner consistent with the Company’s non-employee director compensation policies and programs in effect from time to time. Currently, the Company’s non-employee directors receive an annual cash retainer of $75,000, which is paid in equal installments quarterly. Also in connection with her appointment to the Board, Ms. Ellingsen entered into an indemnification agreement with the Company in the same form that the Company has entered into with its other directors.

 

There are no current or proposed transactions in which Ms. Ellingsen has or will have a direct or indirect material interest and in which the Company is or will be a participant that require disclosure pursuant to Item 404(a) of Regulation S-K. In addition, there are no arrangements or understandings between Ms. Ellingsen and any other person pursuant to which she was appointed as a director.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DASEKE, INC.
     
Date: May 3, 2021 By: /s/ Soumit Roy
  Name: Soumit Roy
  Title: Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary

 

 

Daseke (NASDAQ:DSKE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Daseke Charts.
Daseke (NASDAQ:DSKE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Daseke Charts.